Berry Global’s overall net sales in the quarter were $2.975 billion a 53% increase compared to the prior year quarter. The net sales growth is primarily attributed to RPC acquisition net sales of $1.1 billion and a base volume increase of 2%. These increases were partially offset by lower selling prices of $148 million due to the pass through of lower resin costs and prior quarter divestiture sales of $24 million.

Health, Hygiene & Specialties delivered net sales of $576 million in the March 2020 quarter. The net sales decrease in the Health, Hygiene & Specialties segment is primarily attributed to lower selling prices of $52 million due to the pass through of lower resin costs and prior quarter sales of $24 million related to the divested Seal for Life (SFL) business. These decreases are partially offset by a 3% base volume increase.

Berry’s chairman and CEO Tom Salmon comments, “While there are unprecedented uncertainties impacting the global economy right now, we are fortunate to have an extremely diverse portfolio of products, both geographically and by end market, which will further demonstrate our proven track record of stability as we progress through the back half of fiscal 2020. The long-term fundamentals of the business have strengthened and we remain focused on our top three financial objectives of improving our strong balance sheet, organically growing our businesses, and integrating the RPC acquisition as demonstrated in this recently completed quarter.”